Jennifer’s role focuses on the development of market access materials such as value dossiers, health technology appraisal submissions, objection handlers, and value story slide decks. She has experience across a variety of therapy areas including oncology, respiratory, dermatology, autoimmune, infectious, and orphan diseases. She has also led client workshops and country affiliate interviews to develop product- and country- specific value stories and reimbursement strategies. Jennifer sits on Evidera’s policy trends team as the lead for Canada which enables her to stay up-to-date on global market access trends.
Jennifer obtained her MSc in medical microbiology from the London School of Hygiene and Tropical Medicine focusing on bacterial and viral infectious disease and vaccine immunology. She completed her research project in Southeast Asia (Laos) on antibiotic resistance. Her work has been published in peer-reviewed scientific journals and presented at international conferences.